GlassScriptPhysician profile
Clara Shnaidman
NPI 1801050117
$2,159.17
in general payments reported to CMS, 2019-2025
23 companies · $762 in 2025
The $762 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $47.51 · 2022: $16.20 · 2023: $495 · 2024: $611 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599 · Consulting Fee: $175 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.72 |
| Consulting Fee | $175.00 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $355.41 | 2019-2025 | Prolia, Repatha, Otezla |
| Abbvie INC. | $315.83 | 2022-2025 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $255.67 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $207.07 | 2019-2025 | |
| Astellas Pharma US INC | $189.55 | 2023-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $161.85 | 2023-2025 | Trelegy Ellipta, Bexsero, Penmenvy |
| Astrazeneca Pharmaceuticals LP | $104.26 | 2024 | Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.31 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $83.86 | 2019-2023 | Belsomra, Steglatro |
| Lilly USA, LLC | $66.38 | 2023-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $38.89 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $38.36 | 2019 | |
| Hologic Sales and Service, LLC | $37.02 | 2023 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $37.00 | 2019-2023 | |
| Organogenesis INC. | $27.86 | 2025 | Puraply Wound Matrix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.60 | 2025 | Xifaxan |
| Davol INC. | $23.02 | 2023 | Arista Ah Flexitip |
| Sanofi Pasteur INC. | $17.47 | 2024 | |
| Exeltis, USA INC. | $16.87 | 2025 | Slynd |
| Ibsa Pharma INC. | $16.24 | 2025 | Licart, Flector, Tirosint |
| Renalytix Ai, INC. | $14.25 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $13.20 | 2023 | Freestyle Libre 2 |
| Radius Health, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Shnaidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.